Orlistat inhibits dietary cholesterol absorption (Q43763133)

26 November 2017

Orlistat inhibits dietary cholesterol absorption (English)

1 reference

26 November 2017

Mittendorfer B

1

1 reference

26 November 2017

Ostlund RE Jr

series ordinal

2

1 reference

26 November 2017

Patterson BW

series ordinal

3

1 reference

26 November 2017

Klein S

series ordinal

4

1 reference

26 November 2017

1 October 2001

1 reference

26 November 2017

1 reference

26 November 2017

9

1 reference

26 November 2017

10

1 reference

26 November 2017

599-604

1 reference

Regional adiposity patterns in relation to lipids, lipoprotein cholesterol, and lipoprotein subfraction mass in men.

26 November 2017

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2001.79

Body mass index and the prevalence of hypertension and dyslipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2001.79

Inhibition of pancreatic lipase in vitro by the covalent inhibitor tetrahydrolipstatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2001.79

Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. European Multicentre Orlistat Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2001.79

Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2001.79

Role of orlistat in the treatment of obese patients with type 2 diabetes. A 1-year randomized double-blind study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2001.79

Cholesterol-rich diet induced changes in plasma lipids in relation to apolipoprotein E phenotype in healthy students

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2001.79

Effect of egg yolk feeding on the concentration and composition of serum lipoproteins in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2001.79

Turnover of plasma cholesterol in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2001.79

Absorption of Cholesterol from a Micellar Solution: Intestinal Perfusion Studies in Man*

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2001.79

Hepatic clearance of plasma low density lipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2001.79

By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2001.79

Triglycerides as a risk factor for coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2001.79

Lipoprotein classes and coronary disease regression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2001.79

Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: executive summary. Expert Panel on the Identification, Evaluation, and Treatment of Overweight in Adults

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2001.79

Effects of weight reduction on blood lipids and lipoproteins: a meta-analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2001.79

Retrospective population-based analysis of the dose-response (fecal fat excretion) relationship of orlistat in normal and obese volunteers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2001.79

Independence of the effects of cholesterol and degree of saturation of the fat in the diet on serum cholesterol in man

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2001.79

Quantitative Effects of Dietary Fat on Serum Cholesterol in Man

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2001.79

Effect of dietary egg on variability of plasma cholesterol levels and lipoprotein cholesterol

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2001.79

Effect of apolipoprotein E polymorphism on serum lipid response to the separate modification of dietary fat and dietary cholesterol.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2001.79

Effect of Dietary Cholesterol on Man's Serum Lipids

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2001.79

A Single Blood Sample Dual Isotope Method for the Measurement of Cholesterol Absorption in Rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2001.79

Orlistat, a lipase inhibitor, for weight maintenance after conventional dieting: a 1-y study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2001.79

Theoretical considerations of what regulates low-density-lipoprotein and high-density-lipoprotein cholesterol

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2001.79

What predicts weight regain in a group of successful weight losers? .

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2001.79

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/OBY.2001.79

1 reference

26 November 2017

1 reference